Skip to main content
Log in

Antiarrhythmic Impact of Non-antiarrhythmic Cardiovascular Therapies

  • Published:
Cardiac Electrophysiology Review

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321:406-412.

    Google Scholar 

  2. Spaulding CM, Joly L, Rosenberg A, Monchi M, Weber SN, Dhainaut JA, Carli P. Immediate coronary angiography in survivors of out-of-hospital cardiac arrest. N Engl J Med 1997;336:1629-1633.

    Google Scholar 

  3. Garan H. Ruskin Jn, DiMarco JP, Derkac WM, Akins CW, Daggett WM, Austen WG, Buckley MJ. Electrophysiologic studies before and after myocardial revascularization in patients with life-threatening ventricular arrhythmias. Am J Cardiol 1983;51:519-524.

    Google Scholar 

  4. Bigger JT, for the Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. N Engl J Med 1997;337:1569-1575.

    Google Scholar 

  5. Grossman E, Messerli FH, Grodzicki T, Kowey PR. Should a moratorium be place on sublingual nifedipine? JAMA 1996;276:1328-1332.

    Google Scholar 

  6. Norweigan Multicenter Study Group. Timolol-induced reductionin mortality and reinfarction with long-term beta-adrenoreceptor blockade. Br Med J 1977;2:419-421.

    Google Scholar 

  7. Julian DG, Camm AJ, Franagin G, Janse MJ, Munoz A, Schwartz PJ, Simon P, for the European Myocardial Infarct Amiodarone Trial Investigators. Randomised trial of effect of amiodarone on normality in patients with left ventricular dysfunction of the recent myocardial infarction: EMIAT. Lancet 1997;349:667-674.

    Google Scholar 

  8. Siebels J, Kuck KH. Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study, Hamburg). Am Heart J 1994;127:1139-1144.

    Google Scholar 

  9. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997;336:525-533.

    Google Scholar 

  10. Kober L, Torp-Pederson C, Carlsen JE, et al. A clinical trail of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1995;333:1670-1676.

    Google Scholar 

  11. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996;334:1349-1355.

    Google Scholar 

  12. Zehender M, Faber T, Koscheck U, Meinertz T, Just H. Ventricular tachyarrhythmias, myocardial ischemia, and sudden cardiac death in patients with hypertensive heart disease. Clin Cardiol 1995;18:377-383.

    Google Scholar 

  13. Rials SJ, Wu Ying, Xu X, Filart RA, Marinchak RA, Kowey PR. Regression of left ventricular hypertrophy with captopril restores normal ventricular action potential duration, dispersion of refractoriness, and vulnerability to inducible ventricular fibrillation. Circulation 1997;96:1330-1336.

    Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kowey, P., Marinchak, R.A., Rials, S.J. et al. Antiarrhythmic Impact of Non-antiarrhythmic Cardiovascular Therapies. Card Electrophysiol Rev 2, 123–126 (1998). https://doi.org/10.1023/A:1009959128056

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1009959128056

Keywords

Navigation